Tandem Diabetes Care, Inc. (TNDM) Gross profit 2016–2025
Tandem Diabetes Care, Inc. (TNDM) annual gross profit history from SEC filings — each fiscal year as reported.
$546.0MFY2025 · since FY2016: $23.6M → $546.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $546.0M | +11.5% |
| FY2024 | $489.6M | +33.1% |
| FY2023 | $367.7M | -11.0% |
| FY2022 | $413.0M | +9.8% |
| FY2021 | $376.2M | +44.4% |
| FY2020 | $260.5M | +34.1% |
| FY2019 | $194.2M | +116.2% |
| FY2018 | $89.8M | +103.7% |
| FY2017 | $44.1M | +86.9% |
| FY2016 | $23.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TNDM financial trends
TNDM RevenueTNDM Net incomeTNDM Net marginTNDM Gross marginTNDM Operating incomeTNDM Operating marginTNDM Operating cash flowTNDM Free cash flowTNDM Capital expendituresTNDM Return on equityTNDM Stock buybacksTNDM Dividends paidTNDM Total assetsTNDM Total liabilitiesTNDM Shareholders’ equityTNDM overview →